• Sarepta Therapeutics' (SRPT) "Buy" Rating Reiterated at Needham & Company LLC

    المصدر: Buzz FX / 07 نوفمبر 2024 08:26:16   America/Chicago


    Sarepta Therapeutics' (SRPT) "Buy" Rating Reiterated at Needham & Company LLC Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "buy" rating reiter
    Read more...
شارك على،